Moderna Inc (MRNA)

[axelvento]

(nice)------- stay tuned------
Reason to buy: It has oodles of cash to invest in long-term growth
For a biotech, there's nothing better than having a lot of money to spend on stuff like pioneering new pipeline programs, doing more preclinical research, and building additional platform capabilities. Biotech is a risky business, and the more money a company has, the more chances it has to hit a home run -- and the more times it can safely strike out without endangering its future.

On that note, Moderna ended 2022 with a mind-boggling $18.2 billion in cash, equivalents, and investments, and it plans to spend only $4.5 billion on research and development (R&D) in 2023. That means it could continue to spend like wild even if its earnings were to somehow drop to zero, which they won't.

It also means that the company will be able to easily acquire any promising upstarts that management thinks will be useful, not to mention opening the door to direct investments in key suppliers like Maravai LifeSciences if the need arises.

And that's why having a lot of cash is yet another reason to invest.

Reason to sell: Revenue is going to keep crashing for a while



https://www.fool.com/investing/2023/03/06/2-reasons-to-buy-moderna-stock-1-reason-to-sell/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article